Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines.
Tatsis N, Fitzgerald JC, Reyes-Sandoval A, Harris-McCoy KC, Hensley SE, Zhou D, Lin SW, Bian A, Xiang ZQ, Iparraguirre A, Lopez-Camacho C, Wherry EJ, Ertl HC.
Tatsis N, et al.
Blood. 2007 Sep 15;110(6):1916-23. doi: 10.1182/blood-2007-02-062117. Epub 2007 May 17.
Blood. 2007.
PMID: 17510320
Free PMC article.